In our study, we found that tunicamycin treatment and exogenous expression of active ATF6 (1–373) induced both the mRNA and protein expression of CIP2A in colon cancer cells (Figs 1 and 2). This evidence concerns the gene CIP2A and malignant colon neoplasm.